(VIANEWS) – SunPower Corporation (SPWR), Assertio Holdings (ASRT), Republic Bancorp (RBCAA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SunPower Corporation (SPWR)
31.1% sales growth and 13.66% return on equity
SunPower Corporation delivers solar solutions worldwide. It operates through Residential, Light Commercial; Commercial and Industrial Solutions; and Others segments. The company provides solar energy solutions, including sales to its third-party dealer network and resellers, storage solutions, cash and loan sales, and long-term leases directly to end customers; and sells turn-key engineering, procurement, and construction services, as well as sells energy under power purchase agreements. It also offers commercial roof, carport, and ground mounted systems; and post-installation operations and maintenance services. In addition, the company provides residential leasing program services, as well as sells inverters manufactured by third parties. The company also serves investors, financial institutions, project developers, electric utilities, independent power producers, commercial and governmental entities, production home builders, residential owners, and small commercial building owners. The company was incorporated in 1985 and is headquartered in San Jose, California. SunPower Corporation is a subsidiary of Total Energies Nouvelles Activités USA.
Earnings Per Share
As for profitability, SunPower Corporation has a trailing twelve months EPS of $0.31.
PE Ratio
SunPower Corporation has a trailing twelve months price to earnings ratio of 36.52. Meaning, the purchaser of the share is investing $36.52 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.66%.
2. Assertio Holdings (ASRT)
30.3% sales growth and 53.56% return on equity
Assertio Holdings, Inc., a commercial pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. The company's pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; moderate to severe ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, an NSAID for relief of mild to moderate acute pain; and SPRIX, an NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.
Earnings Per Share
As for profitability, Assertio Holdings has a trailing twelve months EPS of $1.76.
PE Ratio
Assertio Holdings has a trailing twelve months price to earnings ratio of 3.04. Meaning, the purchaser of the share is investing $3.04 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 53.56%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.2%, now sitting on 162.16M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 12.5% and positive 75% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Assertio Holdings’s EBITDA is 176.92.
Yearly Top and Bottom Value
Assertio Holdings’s stock is valued at $5.35 at 01:22 EST, way below its 52-week high of $8.01 and way higher than its 52-week low of $2.07.
3. Republic Bancorp (RBCAA)
26% sales growth and 10.55% return on equity
Republic Bancorp, Inc., a financial holding company, provides various banking products and services in the United States. It operates in five segments: Traditional Banking, Warehouse, Mortgage Banking, Tax Refund Solutions, and Republic Credit Solutions. The company accepts demand, money market accounts, savings, individual retirement accounts, time, brokered, and other certificates of deposit. Its loan products include residential real estate, commercial real estate, construction and land development, home improvement and home equity, secured and unsecured personal, and aircraft loans. The company also offers credit cards; title insurance and other financial products and services; and memory banking, private banking, lockbox processing, remote deposit capture, business online banking, account reconciliation, automated clearing house processing, and internet and mobile banking services. In addition, it provides short-term and revolving credit facilities to mortgage bankers; tax refund solutions, which facilitate the receipt and payment of federal and state tax refund products through third-party tax preparers and tax-preparation software providers; and general purpose reloadable prepaid cards through third party service providers. Further, the company offers consumer credit products; and property and casualty insurance products. As of January 28, 2022, it operated 42 full-service banking centers. Republic Bancorp, Inc. was incorporated in 1974 and is headquartered in Louisville, Kentucky.
Earnings Per Share
As for profitability, Republic Bancorp has a trailing twelve months EPS of $4.59.
PE Ratio
Republic Bancorp has a trailing twelve months price to earnings ratio of 9.96. Meaning, the purchaser of the share is investing $9.96 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.55%.
4. Heritage-Crystal Clean (HCCI)
15.1% sales growth and 22.05% return on equity
Heritage-Crystal Clean, Inc., through its subsidiary, Heritage-Crystal Clean, LLC, provides parts cleaning, hazardous and non-hazardous waste, and used oil collection services to small and mid-sized customers in the industrial and vehicle maintenance sectors in the United States and Canada. It operates through two segments, Environmental Services and Oil Business. The Environmental Services segment offers parts cleaning, containerized waste management, wastewater vacuum, antifreeze recycling, and field services. The Oil Business segment engages in the collection of used oil, the sale of recycled fuel oil, and used oil filter removal and disposal activities, as well as the re-refining of used oil into lubricant base oil and other products. The company also collects and disposes wastewater. As of January 1, 2022, it operated through 91 branches serving approximately 95,000 customer locations. Heritage-Crystal Clean, Inc. was incorporated in 2007 and is headquartered in Elgin, Illinois.
Earnings Per Share
As for profitability, Heritage-Crystal Clean has a trailing twelve months EPS of $3.77.
PE Ratio
Heritage-Crystal Clean has a trailing twelve months price to earnings ratio of 11.07. Meaning, the purchaser of the share is investing $11.07 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.05%.
5. AmerisourceBergen (ABC)
6.4% sales growth and 221.04% return on equity
AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Earnings Per Share
As for profitability, AmerisourceBergen has a trailing twelve months EPS of $7.79.
PE Ratio
AmerisourceBergen has a trailing twelve months price to earnings ratio of 24.03. Meaning, the purchaser of the share is investing $24.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 221.04%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
AmerisourceBergen’s EBITDA is 44.47.
Sales Growth
AmerisourceBergen’s sales growth is 6.2% for the current quarter and 6.4% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.9%, now sitting on 247.54B for the twelve trailing months.
Volume
Today’s last reported volume for AmerisourceBergen is 222267 which is 83.93% below its average volume of 1383360.
